Mitra Biotech, Inc.
Mitra Biotech is a global leader in advancing truly personalized oncology treatment.
Mitra’s CANscript™ platform delivers powerful, individualized treatment response predictions — with exceptionally high correlation to clinical outcomes — to inform truly patient-specific cancer treatment selection and support more effective and efficient cancer drug development.